View in EDS HTML Full Text PDF Full Text

Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.

Saved in:
Bibliographic Details
Title: Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.
Authors: Dal-Pizzol F; Intensive Care Unit, Hospital São José, Criciúma 88806-000, SC, Brazil.; Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil., Lobo SM; Intensive Care Division, Hospital de Base, FAMERP, São José do Rio Preto 15090-000, SP, Brazil., Lucasti C; South Jersey Infectious Disease, 730 Shore Road, Somers Point 08244, NJ, USA., Baidoo AAH; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Su H; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Lan Z; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Source: Vaccines [Vaccines (Basel)] 2025 Mar 31; Vol. 13 (4). Date of Electronic Publication: 2025 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40333222
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dal-Pizzol+F%22">Dal-Pizzol F</searchLink>; Intensive Care Unit, Hospital São José, Criciúma 88806-000, SC, Brazil.; Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.<br /><searchLink fieldCode="AU" term="%22Lobo+SM%22">Lobo SM</searchLink>; Intensive Care Division, Hospital de Base, FAMERP, São José do Rio Preto 15090-000, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Lucasti+C%22">Lucasti C</searchLink>; South Jersey Infectious Disease, 730 Shore Road, Somers Point 08244, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Baidoo+AAH%22">Baidoo AAH</searchLink>; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.<br /><searchLink fieldCode="AU" term="%22Su+H%22">Su H</searchLink>; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.<br /><searchLink fieldCode="AU" term="%22Lan+Z%22">Lan Z</searchLink>; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.<br /><searchLink fieldCode="AU" term="%22Xie+L%22">Xie L</searchLink>; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2025 Mar 31; Vol. 13 (4). <i>Date of Electronic Publication: </i>2025 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40333222
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines13040372
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dal-Pizzol F
      – PersonEntity:
          Name:
            NameFull: Lobo SM
      – PersonEntity:
          Name:
            NameFull: Lucasti C
      – PersonEntity:
          Name:
            NameFull: Baidoo AAH
      – PersonEntity:
          Name:
            NameFull: Su H
      – PersonEntity:
          Name:
            NameFull: Lan Z
      – PersonEntity:
          Name:
            NameFull: Xie L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2025 Mar 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1